Duloxetine Versus Citalopram and Sertraline in the Treatment of Poststroke Depression, Anxiety, and Fatigue
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The authors sought to determine the relative efficacy and tolerability of duloxetine versus citalopram and sertraline in the treatment of poststroke depression (PSD), anxiety, and fatigue. A group of 60 patients with PSD were assigned to receive duloxetine, citalopram, or sertraline and were assessed over a 3-month period for depression, anxiety, and fatigue. Improvement of depression and anxiety, but not fatigue, was observed in all study groups. Duloxetine was well tolerated and significantly more effective than citalopram and sertraline for the treatment of anxiety symptoms in PSD patients. None of the antidepressants used was effective for reducing symptoms of fatigue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
International Trends in Mortality From Stroke, 1968 to 1994
Sarti, C., Rastenyte, D., Cepaitis, Z., & Tuomilehto, J. (2000) · Stroke · doi:10.1161/01.str.31.7.1588 · Cited by 451
Szegedi, A., Jansen, W. T., van Willigenburg, A. P. P., van der Meulen, E., Stassen, H. H., & Thase, M. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.07m03780 · Cited by 341
Papakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C., & Shelton, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.027 · Cited by 308
Wise, T. N., Wiltse, C. G., Iosifescu, D. V., Sheridan, M., Xu, J. Y., & Raskin, J. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01476.x · Cited by 62
Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine
Trivedi, M. H., Desaiah, D., Ossanna, M. J., Pritchett, Y. L., Brannan, S. K., & Detke, M. J. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f41d7e · Cited by 59
Cited by
Winstein, C. J., Stein, J., Arena, R., Bates, B., Cherney, L. R., Cramer, S. C., Deruyter, F., Eng, J. J., Fisher, B., Harvey, R. L., et al. (2016) · Stroke · doi:10.1161/str.0000000000000098 · Cited by 3,293
Fatigue as a symptom or comorbidity of neurological diseases
Penner, I.-K., & Paul, F. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.117 · Cited by 404
Interventions for treating anxiety after stroke
Knapp, P., Campbell Burton, C. A., Holmes, J., Murray, J., Gillespie, D., Lightbody, C. E., Watkins, C. L., Chun, H.-Y. Y., & Lewis, S. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008860.pub3 · Cited by 181
Model of understanding fatigue after stroke
Wu, S., Mead, G., Macleod, M., & Chalder, T. (2015) · Stroke · doi:10.1161/strokeaha.114.006647 · Cited by 169
Metadata
- Authors
- Karaiskos, D., Tzavellas, E., Spengos, K., Vassilopoulou, S., & Paparrigopoulos, T.
- Venue
- The Journal of Neuropsychiatry and Clinical Neurosciences
- Published
- 2012-07
- Volume
- 24
- Issue
- 3
- Pages
- 349-353
- ISSN
- 0895-0172 (ISSN-L)
- 1545-7222
- OpenAlex
- W2171496630
- Cited by
- 97
- References
- 6
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Duloxetine Versus Citalopram and Sertraline in the Treatment of Poststroke Depression, Anxiety, and Fatigue. https://app.cochat.ai/papers/10.1176/appi.neuropsych.11110325
- The paper
- Karaiskos, D., Tzavellas, E., Spengos, K., Vassilopoulou, S., & Paparrigopoulos, T. (2012). Duloxetine Versus Citalopram and Sertraline in the Treatment of Poststroke Depression, Anxiety, and Fatigue. The Journal of Neuropsychiatry and Clinical Neurosciences. https://doi.org/10.1176/appi.neuropsych.11110325
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.